Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (351-360 of 561) with videos related to

Pageof 57
Sort By:
European Urology Focus|November 21, 2018
Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort StudyFrancesco Soria, Marco Moschini, David D'andrea, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2022
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomyReza Sari Motlagh, Victor M Schuettfort, Keiichiro Mori, et al.
European Urology Focus|December 14, 2022
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder CancerTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
European Urology Oncology|May 3, 2022
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Chiara Lonati, Luigi Nocera, et al.
BJU International|October 28, 2024
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancerMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Clinical Genitourinary Cancer|February 2, 2022
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical NephroureterectomyAlberto Martini, Chiara Lonati, Francesco Montorsi, et al.
World Journal of Urology|August 13, 2022
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, et al.
BJU International|December 8, 2022
Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
PD1-IL2v expands and induces effector CD8<sup>+</sup> TILs, but not Tregs, in the BCG treated orthotopic non-muscle invasive bladder cancer modelIrene Locatelli, Marco Lorenzoni, Chiara Venegoni, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Pageof 57

Showing results (351-360 of 561) with videos related to

Sort By:
Pageof 57
European Urology Focus|November 21, 2018
Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort StudyFrancesco Soria, Marco Moschini, David D'andrea, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2022
Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomyReza Sari Motlagh, Victor M Schuettfort, Keiichiro Mori, et al.
European Urology Focus|December 14, 2022
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder CancerTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
European Urology Oncology|May 3, 2022
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial CarcinomaAlberto Martini, Chiara Lonati, Luigi Nocera, et al.
BJU International|October 28, 2024
Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancerMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Clinical Genitourinary Cancer|February 2, 2022
The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical NephroureterectomyAlberto Martini, Chiara Lonati, Francesco Montorsi, et al.
World Journal of Urology|August 13, 2022
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysisKeiichiro Mori, Takafumi Yanagisawa, Satoshi Katayama, et al.
BJU International|December 8, 2022
Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2026
PD1-IL2v expands and induces effector CD8<sup>+</sup> TILs, but not Tregs, in the BCG treated orthotopic non-muscle invasive bladder cancer modelIrene Locatelli, Marco Lorenzoni, Chiara Venegoni, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Pageof 57